ArticleCureus2026
Epithelioid Angiomyolipoma Masquerading as Renal Cell Carcinoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelioid angiomyolipoma (EAML) is a rare variant of angiomyolipoma with malignant behavior characterized by predominantly epithelioid cells and minimal fat, mimicking renal cell carcinoma (RCC) on imaging. Preoperative diagnosis is challenging due to its non-specific clinical and radiological features, necessitating a histopathological examination for accurate diagnosis. Unlike classic angiomyolipoma, EAML can demonstrate aggressive behavior, including local invasion, recurrence, and distant metastasis. Owing to the rarity of the tumor, there is a paucity of data regarding the immunohistochemical markers and molecular profiles for predicting biomarkers in EAML. We report a case of renal EAML in a 23-year-old female with liver and lymph node metastases, which was preoperatively diagnosed as RCC. Histopathological examination and immunohistochemistry favored a diagnosis of EAML. Furthermore, next-generation sequencing confirmed a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.